Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors.

Article Details

Citation

Scholz M, Blobaum AL, Marnett LJ, Hey-Hawkins E

Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors.

Bioorg Med Chem. 2011 May 15;19(10):3242-8. doi: 10.1016/j.bmc.2011.03.054. Epub 2011 Mar 27.

PubMed ID
21524587 [ View in PubMed
]
Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) exert their pharmacological activities by inhibiting cyclooxygenase (COX)-1 and COX-2. Previous studies have shown that esters and amides of non-selective inhibitors such as indomethacin are selective against COX-2, which is the therapeutically relevant isoform. Structure-activity analysis indicates that substituted phenyl rings are tolerated as ester components. In the present study, the introduction of inorganic ortho- and meta-carbaborane moieties was explored with the aim to create COX-2 inhibitors and more importantly to investigate the validity of using these boron clusters as drug entities. Interestingly, only the ortho-carbaborane ester was active whereas the meta isomer was not. A similar lack of inhibitory potency was observed when an adamantyl substituent or alkylene spacers at the carbaborane were introduced in the ester functionality.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
IndomethacinProstaglandin G/H synthase 2IC 50 (nM)750N/AN/ADetails